SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
SaSa
Lv5
1180 积分
2021-11-12 加入
最近求助
最近应助
互助留言
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
7天前
已完结
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
7天前
已完结
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
7天前
已完结
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
11天前
已完结
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial
15天前
已完结
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study
15天前
已完结
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma – a phase II randomised trial
15天前
已完结
Erratum to “Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813–819]”
15天前
已完结
子宫颈透明细胞癌诊治指南(2024年版)
18天前
已关闭
中国恶性胸膜间皮瘤临床诊疗指南(2021版)
19天前
已完结
没有进行任何应助
么么哒
24天前
么么哒
27天前
么么哒
1个月前
么么哒
1个月前
么么哒
1个月前
么么哒
1个月前
么么哒
1个月前
么么哒
1个月前
么么哒
2个月前
么么哒
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论